"10.1371_journal.pone.0003613","plos one","2008-10-31T00:00:00Z","Marc Liesa; Bárbara Borda-d'Água; Gema Medina-Gómez; Christopher J Lelliott; José Carlos Paz; Manuel Rojo; Manuel Palacín; Antonio Vidal-Puig; Antonio Zorzano","Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain; Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom; Department of Biosciences, AstraZeneca R&D, Mölndal, Sweden; Institut de Biochimie et Génétique Cellulaires (IBGC) CNRS UMR5095, Université Victor Segalen, Bordeaux, France","Conceived and designed the experiments: ML AZ. Performed the experiments: ML BBd GMG CJL JCP. Analyzed the data: ML MP AJVP AZ. Contributed reagents/materials/analysis tools: ML GMG CJL MR MP AJVP. Wrote the paper: ML AZ.","Christopher J. Lelliott is an employee and stock-holder of Astra Zeneca R&D.","2008","10","Marc Liesa","ML",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
